Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. (Q35070978)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. |
scientific article |
Statements
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma (English)
Patrick Y Wen
Rebecca A Betensky
Anat Stemmer-Rachamimov
Jennie W Taylor
Jorg Dietrich
Elizabeth R Gerstner
Andrew D Norden
Mikael L Rinne
Diana H Giorgio
Kellis Snodgrass
Alison E Randall
Tracy T Batchelor
20 November 2014